nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.118	0.282	CbGbCtD
Hydralazine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0794	0.19	CbGbCtD
Hydralazine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0758	0.182	CbGbCtD
Hydralazine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0675	0.162	CbGbCtD
Hydralazine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0396	0.095	CbGbCtD
Hydralazine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0374	0.0897	CbGbCtD
Hydralazine—RYR2—smooth muscle tissue—chronic obstructive pulmonary disease	0.0167	0.124	CbGeAlD
Hydralazine—RYR2—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.0156	0.165	CbGpPWpGaD
Hydralazine—AOC3—respiratory system—chronic obstructive pulmonary disease	0.0125	0.0924	CbGeAlD
Hydralazine—RYR2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0114	0.121	CbGpPWpGaD
Hydralazine—RYR2—lung—chronic obstructive pulmonary disease	0.011	0.0815	CbGeAlD
Hydralazine—AOC3—connective tissue—chronic obstructive pulmonary disease	0.011	0.0814	CbGeAlD
Hydralazine—AOC3—bronchus—chronic obstructive pulmonary disease	0.0103	0.0761	CbGeAlD
Hydralazine—RYR2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0102	0.108	CbGpPWpGaD
Hydralazine—AOC3—smooth muscle tissue—chronic obstructive pulmonary disease	0.01	0.0744	CbGeAlD
Hydralazine—P4HA1—respiratory system—chronic obstructive pulmonary disease	0.00996	0.0739	CbGeAlD
Hydralazine—AOC3—trachea—chronic obstructive pulmonary disease	0.00921	0.0683	CbGeAlD
Hydralazine—P4HA1—connective tissue—chronic obstructive pulmonary disease	0.00877	0.0651	CbGeAlD
Hydralazine—P4HA1—bronchus—chronic obstructive pulmonary disease	0.0082	0.0608	CbGeAlD
Hydralazine—P4HA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00802	0.0595	CbGeAlD
Hydralazine—P4HA1—trachea—chronic obstructive pulmonary disease	0.00736	0.0546	CbGeAlD
Hydralazine—AOC3—lung—chronic obstructive pulmonary disease	0.00662	0.0491	CbGeAlD
Hydralazine—P4HA1—lung—chronic obstructive pulmonary disease	0.00529	0.0392	CbGeAlD
Hydralazine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00468	0.0495	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00413	0.0437	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00397	0.042	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00354	0.0374	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00344	0.0364	CbGpPWpGaD
Hydralazine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00338	0.0358	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.0031	0.0328	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00253	0.0267	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00215	0.0227	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.0019	0.0201	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00172	0.0182	CbGpPWpGaD
Hydralazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00168	0.00475	CcSEcCtD
Hydralazine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00473	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.00472	CcSEcCtD
Hydralazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.00467	CcSEcCtD
Hydralazine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00159	0.0045	CcSEcCtD
Hydralazine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00448	CcSEcCtD
Hydralazine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.00434	CcSEcCtD
Hydralazine—Hepatomegaly—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00432	CcSEcCtD
Hydralazine—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00431	CcSEcCtD
Hydralazine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00431	CcSEcCtD
Hydralazine—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00423	CcSEcCtD
Hydralazine—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00423	CcSEcCtD
Hydralazine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00148	0.00418	CcSEcCtD
Hydralazine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00417	CcSEcCtD
Hydralazine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00415	CcSEcCtD
Hydralazine—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00415	CcSEcCtD
Hydralazine—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00415	CcSEcCtD
Hydralazine—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00414	CcSEcCtD
Hydralazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.0041	CcSEcCtD
Hydralazine—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.00145	0.0041	CcSEcCtD
Hydralazine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.00403	CcSEcCtD
Hydralazine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00402	CcSEcCtD
Hydralazine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.004	CcSEcCtD
Hydralazine—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00399	CcSEcCtD
Hydralazine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.00394	CcSEcCtD
Hydralazine—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00391	CcSEcCtD
Hydralazine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00382	CcSEcCtD
Hydralazine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00134	0.0038	CcSEcCtD
Hydralazine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00134	0.0038	CcSEcCtD
Hydralazine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00379	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS3—chronic obstructive pulmonary disease	0.00133	0.0141	CbGpPWpGaD
Hydralazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00374	CcSEcCtD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00132	0.0139	CbGpPWpGaD
Hydralazine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00372	CcSEcCtD
Hydralazine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00367	CcSEcCtD
Hydralazine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00361	CcSEcCtD
Hydralazine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00358	CcSEcCtD
Hydralazine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00358	CcSEcCtD
Hydralazine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00356	CcSEcCtD
Hydralazine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00347	CcSEcCtD
Hydralazine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.00347	CcSEcCtD
Hydralazine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00344	CcSEcCtD
Hydralazine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00344	CcSEcCtD
Hydralazine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00344	CcSEcCtD
Hydralazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00342	CcSEcCtD
Hydralazine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00342	CcSEcCtD
Hydralazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.0034	CcSEcCtD
Hydralazine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00337	CcSEcCtD
Hydralazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00335	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00118	0.0124	CbGpPWpGaD
Hydralazine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00331	CcSEcCtD
Hydralazine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00327	CcSEcCtD
Hydralazine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00327	CcSEcCtD
Hydralazine—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00325	CcSEcCtD
Hydralazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.00325	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—chronic obstructive pulmonary disease	0.00113	0.012	CbGpPWpGaD
Hydralazine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00321	CcSEcCtD
Hydralazine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00113	0.0032	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.00113	0.0119	CbGpPWpGaD
Hydralazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00318	CcSEcCtD
Hydralazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00318	CcSEcCtD
Hydralazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00317	CcSEcCtD
Hydralazine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00315	CcSEcCtD
Hydralazine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00315	CcSEcCtD
Hydralazine—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00313	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00313	CcSEcCtD
Hydralazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00312	CcSEcCtD
Hydralazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00312	CcSEcCtD
Hydralazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00312	CcSEcCtD
Hydralazine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00309	CcSEcCtD
Hydralazine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00308	CcSEcCtD
Hydralazine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00306	CcSEcCtD
Hydralazine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00306	CcSEcCtD
Hydralazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00306	CcSEcCtD
Hydralazine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00302	CcSEcCtD
Hydralazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00301	CcSEcCtD
Hydralazine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.003	CcSEcCtD
Hydralazine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00106	0.003	CcSEcCtD
Hydralazine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00298	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00297	CcSEcCtD
Hydralazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00295	CcSEcCtD
Hydralazine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00294	CcSEcCtD
Hydralazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00294	CcSEcCtD
Hydralazine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00289	CcSEcCtD
Hydralazine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00289	CcSEcCtD
Hydralazine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00289	CcSEcCtD
Hydralazine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00289	CcSEcCtD
Hydralazine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00289	CcSEcCtD
Hydralazine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00289	CcSEcCtD
Hydralazine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00102	0.0108	CbGpPWpGaD
Hydralazine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00288	CcSEcCtD
Hydralazine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00288	CcSEcCtD
Hydralazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00288	CcSEcCtD
Hydralazine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00286	CcSEcCtD
Hydralazine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00286	CcSEcCtD
Hydralazine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00283	CcSEcCtD
Hydralazine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.001	0.00283	CcSEcCtD
Hydralazine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.001	0.00283	CcSEcCtD
Hydralazine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000997	0.00282	CcSEcCtD
Hydralazine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000979	0.00277	CcSEcCtD
Hydralazine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000979	0.00277	CcSEcCtD
Hydralazine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000965	0.00273	CcSEcCtD
Hydralazine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000965	0.00273	CcSEcCtD
Hydralazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000964	0.00273	CcSEcCtD
Hydralazine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000961	0.00272	CcSEcCtD
Hydralazine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000959	0.00272	CcSEcCtD
Hydralazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000956	0.00271	CcSEcCtD
Hydralazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000956	0.00271	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000955	0.0101	CbGpPWpGaD
Hydralazine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000953	0.0027	CcSEcCtD
Hydralazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000948	0.00268	CcSEcCtD
Hydralazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000939	0.00266	CcSEcCtD
Hydralazine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000925	0.00262	CcSEcCtD
Hydralazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000915	0.00259	CcSEcCtD
Hydralazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000915	0.00259	CcSEcCtD
Hydralazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00091	0.00258	CcSEcCtD
Hydralazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00256	CcSEcCtD
Hydralazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000894	0.00253	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000892	0.00253	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000892	0.00253	CcSEcCtD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000886	0.00937	CbGpPWpGaD
Hydralazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000881	0.0025	CcSEcCtD
Hydralazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00088	0.00249	CcSEcCtD
Hydralazine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000877	0.00248	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000874	0.00247	CcSEcCtD
Hydralazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000873	0.00247	CcSEcCtD
Hydralazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000873	0.00247	CcSEcCtD
Hydralazine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000865	0.00245	CcSEcCtD
Hydralazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000864	0.00245	CcSEcCtD
Hydralazine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000862	0.00244	CcSEcCtD
Hydralazine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000862	0.00244	CcSEcCtD
Hydralazine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000861	0.00244	CcSEcCtD
Hydralazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000859	0.00243	CcSEcCtD
Hydralazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000851	0.00241	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000845	0.00239	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000845	0.00239	CcSEcCtD
Hydralazine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000844	0.00239	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000842	0.00239	CcSEcCtD
Hydralazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000837	0.00237	CcSEcCtD
Hydralazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000837	0.00237	CcSEcCtD
Hydralazine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00083	0.00235	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00234	CcSEcCtD
Hydralazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000824	0.00233	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000818	0.00866	CbGpPWpGaD
Hydralazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000818	0.00232	CcSEcCtD
Hydralazine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000815	0.00231	CcSEcCtD
Hydralazine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000814	0.0023	CcSEcCtD
Hydralazine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000814	0.0023	CcSEcCtD
Hydralazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000811	0.0023	CcSEcCtD
Hydralazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000811	0.00229	CcSEcCtD
Hydralazine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000808	0.00229	CcSEcCtD
Hydralazine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00228	CcSEcCtD
Hydralazine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00228	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000806	0.00853	CbGpPWpGaD
Hydralazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000806	0.00228	CcSEcCtD
Hydralazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000804	0.00228	CcSEcCtD
Hydralazine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000803	0.00227	CcSEcCtD
Hydralazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000802	0.00227	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000798	0.00226	CcSEcCtD
Hydralazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000791	0.00224	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000779	0.00824	CbGpPWpGaD
Hydralazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000778	0.0022	CcSEcCtD
Hydralazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000778	0.0022	CcSEcCtD
Hydralazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000774	0.00219	CcSEcCtD
Hydralazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000774	0.00219	CcSEcCtD
Hydralazine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000772	0.00817	CbGpPWpGaD
Hydralazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000772	0.00218	CcSEcCtD
Hydralazine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000766	0.00217	CcSEcCtD
Hydralazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000765	0.00217	CcSEcCtD
Hydralazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000764	0.00216	CcSEcCtD
Hydralazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000764	0.00216	CcSEcCtD
Hydralazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000762	0.00216	CcSEcCtD
Hydralazine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00216	CcSEcCtD
Hydralazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00076	0.00215	CcSEcCtD
Hydralazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000758	0.00215	CcSEcCtD
Hydralazine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000741	0.00784	CbGpPWpGaD
Hydralazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00208	CcSEcCtD
Hydralazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000731	0.00207	CcSEcCtD
Hydralazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000722	0.00204	CcSEcCtD
Hydralazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000722	0.00204	CcSEcCtD
Hydralazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000721	0.00204	CcSEcCtD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000713	0.00754	CbGpPWpGaD
Hydralazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000707	0.002	CcSEcCtD
Hydralazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000693	0.00196	CcSEcCtD
Hydralazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000693	0.00196	CcSEcCtD
Hydralazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00193	CcSEcCtD
Hydralazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000679	0.00192	CcSEcCtD
Hydralazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00067	0.0019	CcSEcCtD
Hydralazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00067	0.0019	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	0.000664	0.00702	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.00066	0.00698	CbGpPWpGaD
Hydralazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000656	0.00186	CcSEcCtD
Hydralazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000654	0.00185	CcSEcCtD
Hydralazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000648	0.00183	CcSEcCtD
Hydralazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.00183	CcSEcCtD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000644	0.00681	CbGpPWpGaD
Hydralazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000634	0.0018	CcSEcCtD
Hydralazine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000634	0.00179	CcSEcCtD
Hydralazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000633	0.00179	CcSEcCtD
Hydralazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000623	0.00176	CcSEcCtD
Hydralazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000623	0.00176	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000618	0.00654	CbGpPWpGaD
Hydralazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00175	CcSEcCtD
Hydralazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00175	CcSEcCtD
Hydralazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00175	CcSEcCtD
Hydralazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00175	CcSEcCtD
Hydralazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00174	CcSEcCtD
Hydralazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00174	CcSEcCtD
Hydralazine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000613	0.00174	CcSEcCtD
Hydralazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000611	0.00173	CcSEcCtD
Hydralazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00061	0.00173	CcSEcCtD
Hydralazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000605	0.00171	CcSEcCtD
Hydralazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00171	CcSEcCtD
Hydralazine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000603	0.00171	CcSEcCtD
Hydralazine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000603	0.00171	CcSEcCtD
Hydralazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000601	0.0017	CcSEcCtD
Hydralazine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000592	0.00168	CcSEcCtD
Hydralazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.00166	CcSEcCtD
Hydralazine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000586	0.00166	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000586	0.0062	CbGpPWpGaD
Hydralazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.00165	CcSEcCtD
Hydralazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00165	CcSEcCtD
Hydralazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00165	CcSEcCtD
Hydralazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00165	CcSEcCtD
Hydralazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00164	CcSEcCtD
Hydralazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00057	0.00161	CcSEcCtD
Hydralazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00156	CcSEcCtD
Hydralazine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000547	0.00155	CcSEcCtD
Hydralazine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00153	CcSEcCtD
Hydralazine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000539	0.0057	CbGpPWpGaD
Hydralazine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00053	0.0015	CcSEcCtD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000518	0.00548	CbGpPWpGaD
Hydralazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000518	0.00147	CcSEcCtD
Hydralazine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000503	0.00143	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000485	0.00513	CbGpPWpGaD
Hydralazine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.00135	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000468	0.00495	CbGpPWpGaD
Hydralazine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00124	CcSEcCtD
Hydralazine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000437	0.00124	CcSEcCtD
Hydralazine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000436	0.00124	CcSEcCtD
Hydralazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000434	0.00123	CcSEcCtD
Hydralazine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000426	0.00121	CcSEcCtD
Hydralazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.00119	CcSEcCtD
Hydralazine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000402	0.00114	CcSEcCtD
Hydralazine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000402	0.00114	CcSEcCtD
Hydralazine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000401	0.00113	CcSEcCtD
Hydralazine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00112	CcSEcCtD
Hydralazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.00111	CcSEcCtD
Hydralazine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00109	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.00403	CbGpPWpGaD
Hydralazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000376	0.00106	CcSEcCtD
Hydralazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000367	0.00104	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000351	0.000994	CcSEcCtD
Hydralazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000993	CcSEcCtD
Hydralazine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000346	0.00098	CcSEcCtD
Hydralazine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000339	0.000961	CcSEcCtD
Hydralazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000335	0.000949	CcSEcCtD
Hydralazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.000947	CcSEcCtD
Hydralazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.000946	CcSEcCtD
Hydralazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.000941	CcSEcCtD
Hydralazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00033	0.000933	CcSEcCtD
Hydralazine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000899	CcSEcCtD
Hydralazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.000892	CcSEcCtD
Hydralazine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000315	0.00333	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000308	0.00326	CbGpPWpGaD
Hydralazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000306	0.000867	CcSEcCtD
Hydralazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000305	0.000863	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000304	0.00321	CbGpPWpGaD
Hydralazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000804	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00293	CbGpPWpGaD
Hydralazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000772	CcSEcCtD
Hydralazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000747	CcSEcCtD
Hydralazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000722	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00025	0.00264	CbGpPWpGaD
Hydralazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000694	CcSEcCtD
Hydralazine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000688	CcSEcCtD
Hydralazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000687	CcSEcCtD
Hydralazine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000684	CcSEcCtD
Hydralazine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000648	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000224	0.00237	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00233	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.00192	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000159	0.00169	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000158	0.00167	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.0014	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00138	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000111	0.00117	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000109	0.00115	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000102	0.00107	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.0001	0.00106	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.63e-05	0.00102	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.5e-05	0.001	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.75e-05	0.000819	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.13e-05	0.000543	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.99e-05	0.000528	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.64e-05	0.000491	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.73e-05	0.000288	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.7e-05	0.000285	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.46e-05	0.00026	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.27e-05	0.00024	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.89e-05	0.0002	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.86e-05	0.000197	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.74e-05	0.000184	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.65e-05	0.000174	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000118	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.07e-05	0.000113	CbGpPWpGaD
